Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Nucleic acid-binding proteins (NABPs) exhibit cell type–specific regulatory functions, but their target genes and biological roles remain incompletely characterized due to the limitations of current experimental approaches. Here, we present a deep learning framework that integrates gene co-expression correlations to predict NABP regulatory targets and infer their functions across diverse cellular ...
Despite its potential in cancer therapy, single-atom nanozyme (SAzyme) faces challenges like low atomic loading and rapid cancer metabolism. Here, a high-entropy atom nanozyme (HEAzyme), PtNiBiSnSb-anti-CD36, is designed for efficient anti-tumor immunotherapy. The PtNiBiSnSb HEAzyme, incorporating five SAzyme, demonstrates enhanced peroxidase (POD)-like activity due to its abundant active sites, s...
Despite improved outcomes with atezolizumab plus bevacizumab (A+B) in hepatocellular carcinoma (HCC), primary refractoriness (PRef), characterised by ...
Deep learning models that predict functional genomic measurements from DNA sequence are powerful tools for deciphering the genetic regulatory code. Ex...
Single-cell and spatial proteomic technologies capture complementary biological information, yet no single platform can measure all modalities within ...
We present a novel pipeline combining Multi-Omics Factor Analysis (MOFA) and fine-tuned Large Language Models (LLMs) to predict breast cancer subtypes...
The integration of multi-modal genomic data for cancer classification remains challenging in precision oncology. While machine learning approaches hav...
Allosteric communication between non-contacting sites in proteins plays a fundamental role in biological regulation and drug action. While allosteric ...
Breast cancer exhibits substantial inter- and intra-patient heterogeneity. Yet the molecular features underlying this diversity and their roles in tum...
The accurate prediction of chromosomal instability from the morphology of circulating tumor cells (CTCs) enables real-time detection of CTCs with high...
Cancer cells undergo extensive metabolic rewiring to support growth, survival, and phenotypic plasticity. A non-canonical variant of the tricarboxylic...
Cancer subtype classification is critical for precision therapy and there is a growing trend of augmenting histopathology testing procedures with omic...
The immune system is an intricately evolved series of cellular and protein-protein interactions, which defend the body against pathogens and abnormal ...
Accurate cancer subtyping with accompanying molecular characterization is critical for precision oncology. While machine learning approaches have been...
Colorectal cancer (CRC) ranks as the third highest incidence among malignancies in humans and the second most common cause of cancer-related mortality...
Intratumoral heterogeneity, originating from genetic, epigenetic, and phenotypic cellular diversity, is pervasive in cancer. As these heterogeneous st...
The development of personalized cancer vaccines relies heavily on accurately identifying neoepitopes capable of eliciting strong immune responses. T c...
Chimeric antigen receptor (CAR) T cell therapy holds transformative potential for hematologic malignancies, yet predicting patient-specific treatment ...
Recent advancements in nondestructive 3D pathology offer a complement to standard histology by enabling comprehensive volumetric analyses of intact cl...
In computational modeling, Bounded Linear Temporal Logic (BLTL) is a valuable formalism for describing and verifying the temporal behavior of biologic...